Ensysce Biosciences (ENSC) Notes Payables (2020 - 2025)
Ensysce Biosciences (ENSC) posted Notes Payables of $306,708 for Q4 2025, up 1.7% from $301,660 a year earlier but down 20.9% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Notes Payables (2020 - 2025) Analysis & Trends
Since Q4 2020, Ensysce Biosciences has reported Notes Payables for 18 quarters.
- Annual Notes Payables shows a five-year compound annual growth rate of -40.9% (FY2020 to FY2025).
- In prior years, Ensysce Biosciences' Notes Payables was $301,660 in FY2024 (-64.7%), $854,697 in FY2023 (-80.0%), $4.27 million in FY2022 (-66.5%) and $12.75 million in FY2021 (+200.3%).
- Quarterly Notes Payables has run from a low of $245,973 in Q1 2024 to a high of $12.75 million in Q4 2021 over five years.
- On a year-over-year basis, Notes Payables increased in five of the last seven quarters, with an average decline of 7.5%.
- The strongest year-over-year quarter for Notes Payables in the past five years was Q4 2021, with growth of 200.3%; the weakest was Q3 2023, with a decline of 95.4%.
- According to Business Quant data, Notes Payables for the three prior quarters was $387,702 (Q3 2025), $424,521 (Q2 2025) and $257,383 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.25 Bn | 1,104.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.56 Bn | 534.09 Bn | 17.26 Bn |
| 3 | AbbVie | 506.32 Bn | 479.44 Bn | 12.70 Bn |
| 4 | Merck | 367.72 Bn | 322.10 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.15 Bn | 262.14 Bn | 11.24 Bn |
| 6 | Astrazeneca | 262.32 Bn | 236.01 Bn | 12.86 Bn |
| 7 | Amgen | 236.40 Bn | 191.80 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.30 Bn | 165.50 Bn | 6.22 Bn |
| 9 | Pfizer | 170.97 Bn | 117.62 Bn | 10.94 Bn |
| 10 | Ensysce Biosciences | 1.29 Mn | -9.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 306,708.00 |
| Sep 30, 2025 | 387,702.00 |
| Jun 30, 2025 | 424,521.00 |
| Mar 31, 2025 | 257,383.00 |
| Dec 31, 2024 | 301,660.00 |
| Sep 30, 2024 | 387,176.00 |
| Jun 30, 2024 | 454,463.00 |
| Mar 31, 2024 | 245,973.00 |
| Dec 31, 2023 | 854,697.00 |
| Sep 30, 2023 | 350,932.00 |
| Jun 30, 2023 | 445,738.00 |
| Dec 31, 2022 | 4.27 Mn |
| Sep 30, 2022 | 7.55 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 6.07 Mn |
| Dec 31, 2021 | 12.75 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Dec 31, 2020 | 4.25 Mn |
API Access
Ensysce Biosciences Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();